详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu 610041, Sichuan, China

出处：

DOI：

关键词： s Interleukin-6 Respiratory diseases Therapeutic target Mendelian randomization

摘要：

Dysregulation of inflammation can lead to multiple chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. Interleukin-6 (IL6) is crucial in regulating the inflammatory cascade, but the causal link between IL6 signaling downregulation and respiratory diseases risk is unclear. This study uses Mendelian randomization to examine the effects of IL6R blockade on respiratory diseases. Analyzing data from 522,681 Europeans, 26 genetic variants were obtained to mimic IL6R inhibition. Our findings show that IL6R blockade significantly reduces the risk of COPD (OR = 0.71, 95% CI = 0.60-9.84) and asthma (OR = 0.82, 95% CI = 0.74-0.90), with protective trends for bronchitis, pulmonary embolism, and lung cancer. Results were consistent across methods, with no significant heterogeneity or pleiotropy. These insights suggest IL6R downregulation as a potential therapeutic target for respiratory diseases, meriting further clinical investigation.© 2024. The Author(s).

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 2 区

医学

小类 | 2 区医学：研究与实验

最新[2023]版：

大类 | 2 区

医学

小类 | 2 区医学：研究与实验

第一作者：

第一作者机构： [1]Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu 610041, Sichuan, China

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Therapeutic targets for age-related macular degeneration: proteome-wide Mendelian randomization and colocalization analyses [2]Causal Associations Between Educational Attainment and 14 Urological and Reproductive Health Outcomes: A Mendelian Randomization Study. [3]Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses [4]Copper and Melanoma Risk: Results from NHANES 2007-2018 and Mendelian Randomization Analyses [5]Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. [6]Do Obesity-Related Traits Affect Prostate Cancer Risk through Serum Testosterone? A Mendelian Randomization Study [7]Causal effects of gut microbiota on renal tumor: a mendelian randomization study [8]CD25: A potential tumor therapeutic target [9]Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study. [10]Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: a Mendelian randomization study.